Bradley J Ph D Bolzon is Director of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 21,851 shares of BDTX, which is worth approximately $52,879. The most recent transaction as insider was on Dec 14, 2020, when has been sold 11 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K
0% 3M change
0% 12M change
Total Value Held $52,879

Bradley J PhD Bolzon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2020
BUY
Other acquisition or disposition
-
11 Added 0.05%
21,851 Common Stock
Nov 30 2020
BUY
Other acquisition or disposition
-
15 Added 0.07%
21,840 Common Stock
Nov 27 2020
BUY
Other acquisition or disposition
-
2,256 Added 9.37%
21,825 Common Stock
Nov 23 2020
BUY
Other acquisition or disposition
-
3,935 Added 16.74%
19,569 Common Stock
Nov 11 2020
BUY
Other acquisition or disposition
-
5,456 Added 25.87%
15,634 Common Stock
Oct 07 2020
BUY
Other acquisition or disposition
-
1,471 Added 12.63%
10,178 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BJP

Bradley J Ph D Bolzon

Director
Cambridge, MA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX